What to know:
- Injective’s MACD bullish crossover signals a potential trend reversal as analysts watch key resistance.
- INJ price remains supported by whale accumulation, boosting bullish recovery expectations.
- Injective filed for a U.S. SEC transfer agent license to expand its RWA strategy.
Injective (INJ) is gaining bullish attention as its MACD crossover signals strengthening momentum, while its latest regulatory milestones in the United States and Europe support expansion into real-world assets, reinforcing confidence in the network’s long-term growth and institutional adoption.
At the time of writing, INJ is trading at $5.18 with a 24-hour trading volume of $110.73 million and a market capitalization of $518.24 million. Following the positive momentum, the INJ price structure and network expansion point to a bullish reversal ahead.
Source: CoinMarketCap
Also Read: Injective MiCA Whitepaper Strengthens INJ’s Regulatory Position Across Europe
Injective MACD Crossover Signals Bullish Rally to $50+
According to the crypto analyst Javon Marks, INJ has returned to focus after its moving average convergence divergence (MACD) maintained a bullish crossover, a technical signal often associated with trend reversals.
Analysts noted that the previous crossover of similar magnitude preceded a remarkable rally, prompting traders to closely monitor whether INJ can build sustained momentum above key resistance levels ahead.
Source: Javon Marks’s X Post
Despite warnings that past performance is not indicative of future movements, the revitalized bullish pattern has created more optimism in the market.
It will be important to see increased trading volumes and persistent buying pressure for a successful breakout above $50. Currently, the MACD cross is a highly awaited indicator that supports INJ’s bullish position.
Injective Expands RWA Push With SEC Filing
The data from Injective further highlighted that the network has improved its regulatory position by applying for a transfer agent license from the Securities and Exchange Commission of the United States and, at the same time, publishing its MiCA whitepaper in Europe.
These two developments mark the foundation for scaling up the issuance of real-world assets compliantly and for making institutions accessible to global financial markets.
Source: Injective’s X Post
The latest regulatory developments support Injective’s overall objective of combining the traditional finance system with decentralized technology using compliant protocols.
Following the regulations of the United States and Europe, the blockchain hopes to increase the adoption rate of tokenized assets as well as the utility of the INJ coin.
Following the bullish price predictions and strong network growth, the INJ price is moving in an upward direction. However, the general trend in the crypto market is still cautious, and a breakout could turn into a fakeout if conditions remain unchanged.
What Happens Next?
If Injective capitalizes on its ongoing bull run and buying momentum continues to build up, a break above critical resistance would signal that the cryptocurrency’s bounce is underway.
Regulatory wins and the development of Injective’s real-life asset ecosystem have the potential to attract more institutional attention, which would boost INJ’s adoption and drive its price higher.
Also Read: Injective Price Holds Critical Support With $6.50 in Focus After Coinbase Listing
This article contains market analysis and price predictions. These are not guarantees. Crypto markets are volatile. Always DYOR. Not financial advice.
Be the first to comment